首页> 外文OA文献 >Enhanced Infectivity of an R5-Tropic Simian/Human Immunodeficiency Virus Carrying Human Immunodeficiency Virus Type 1 Subtype C Envelope after Serial Passages in Pig-Tailed Macaques (Macaca nemestrina)
【2h】

Enhanced Infectivity of an R5-Tropic Simian/Human Immunodeficiency Virus Carrying Human Immunodeficiency Virus Type 1 Subtype C Envelope after Serial Passages in Pig-Tailed Macaques (Macaca nemestrina)

机译:猪尾猕猴(Macaca nemestrina)连续传代后携带人免疫缺陷病毒1型C亚型的R5-热带猿猴/人类免疫缺陷病毒的感染力增强。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The increasing prevalence of human immunodeficiency virus type 1 (HIV-1) subtype C infection worldwide calls for efforts to develop a relevant animal model for evaluating strategies against the transmission of the virus. A chimeric simian/human immunodeficiency virus (SHIV), SHIVCHN19, was generated with a primary, non-syncytium-inducing HIV-1 subtype C envelope from a Chinese strain in the background of SHIV33. Unlike R5-tropic SHIV162, SHIVCHN19 was not found to replicate in rhesus CD4+ T lymphocytes. SHIVCHN19 does, however, replicate in CD4+ T lymphocytes of pig-tailed macaques (Macaca nemestrina). The observed replication competence of SHIVCHN19 requires the full tat/rev genes and partial gp41 region derived from SHIV33. To evaluate in vivo infectivity, SHIVCHN19 was intravenously inoculated, at first, into two pig-tailed and two rhesus macaques. Although all four animals became infected, the virus replicated preferentially in pig-tailed macaques with an earlier plasma viral peak and a faster seroconversion. To determine whether in vivo adaptation would enhance the infectivity of SHIVCHN19, passages were carried out serially in three groups of two pig-tailed macaques each, via intravenous blood-bone marrow transfusion. The passages greatly enhanced the infectivity of the virus as shown by the increasingly elevated viral loads during acute infection in animals with each passage. Moreover, the doubling time of plasma virus during acute infection became much shorter in passage 4 (P4) animals (0.2 day) in comparison to P1 animals (1 to 2 days). P2 to P4 animals all became seropositive around 2 to 3 weeks postinoculation and had a decline in CD4/CD8 T-cell ratio during the early phase of infection. In P4 animals, a profound depletion of CD4 T cells in the lamina propria of the jejunum was observed. Persistent plasma viremia has been found in most of the infected animals with sustained viral loads ranging from 103 to 105 per ml up to 6 months postinfection. Serial passages did not change the viral phenotype as confirmed by the persistence of the R5 tropism of SHIVCHN19 isolated from P4 animals. In addition, the infectivity of SHIVCHN19 in rhesus peripheral blood mononuclear cells was also increased after in vivo passages. Our data indicate that SHIVCHN19 has adapted well to grow in macaque cells. This established R5-tropic SHIVCHN19/macaque model would be very useful for HIV-1 subtype C vaccine and pathogenesis studies.
机译:在世界范围内,人类免疫缺陷病毒1型(HIV-1)C亚型感染的患病率日益上升,要求人们努力开发一种相关的动物模型,以评估针对该病毒传播的策略。嵌合猿猴/人类免疫缺陷病毒(SHIV)SHIVCHN19是在SHIV33的背景下从中国毒株中产生的一种非合胞子原代HIV-1亚型C包膜。与R5嗜性SHIV162不同,未发现SHIVCHN19在恒河猴CD4 + T淋巴细胞中复制。但是,SHIVCHN19确实在猪尾猕猴(Macaca nemestrina)的CD4 + T淋巴细胞中复制。观察到的SHIVCHN19的复制能力需要完整的tat / rev基因和源自SHIV33的部分gp41区。为了评估体内感染性,首先将SHIVCHN19静脉内接种到两只猪尾和两只恒河猴中。尽管所有四只动物都被感染,但该病毒优先在猪尾猕猴中复制,血浆病毒峰值更早,血清转化更快。为了确定体内适应性是否会增强SHIVCHN19的感染性,通过静脉输血将骨髓分为两组,每组两只猪尾猕猴。每次传代,在动物急性感染过程中,病毒载量的不断升高表明,传代极大地增强了病毒的感染力。此外,与P1动物(1-2天)相比,第4代(P4)动物(0.2天)在急性感染期间血浆病毒的倍增时间变得更短。接种后约2至3周,P2至P4动物都呈血清反应阳性,并且在感染的早期阶段CD4 / CD8 T细胞比率下降。在P4动物中,观察到空肠固有层中CD4 T细胞的大量消耗。在大多数感染动物中发现了持久性血浆病毒血症,感染后6个月内持续病毒载量为每毫升103至105。从P4动物分离的SHIVCHN19的R5向性的持久性证实,连续传代没有改变病毒表型。此外,体内传代后,SHIVCHN19在恒河猴外周血单个核细胞中的感染性也增加了。我们的数据表明,SHIVCHN19非常适合在猕猴细胞中生长。这种建立的R5嗜性SHIVCHN19 /猕猴模型对于HIV-1亚型C疫苗和发病机理研究将非常有用。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号